Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Edwards Lifesciences Corporation Common Stock (EW) vs NetEase Inc (NTES) Price & Performance

Edwards Lifesciences Corporation Common StockTrade
NetEase IncTrade

Price performance (Past 24H)

Key statistics

Edwards Lifesciences Corporation Common Stock vs NetEase Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while NetEase Inc trades at $122.67 (market cap $76.90B). The key difference: NetEase Inc is the larger of the two by market cap, and NetEase Inc pays a 2.43% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.

EWNTES
Market Cap
$49.44B$76.90B
Volume
3,508,027494,839
Sector
HealthTechnology
52-Week High
$95.18$152.85
52-Week Low
$72.65$109.26
Enterprise Value
$45.90B$52.62B
Typical Hold Time
—74 Days
Dividend Yield
—2.43%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Edwards Lifesciences Corporation Common Stock

No Aura AI signal available yet.

NetEase Inc

NTES trades at $119.60, up 0.45% today, with a neutral technical signal. The company reported Q2 2026 revenue of $4.4 billion, up 8% year-over-year, though EPS missed estimates due to investment losses. Gross margins improved significantly, and the balance sheet remains strong with $137.58 billion in cash. Revenue growth has been steady, with 2025 revenue reaching $112.63 billion and net income at $33.76 billion.

The outlook is positive given strong profitability, a robust balance sheet, and analyst consensus favoring a buy rating with a $168 price target. Risks include earnings volatility, competitive pressures in gaming, and macroeconomic headwinds affecting Chinese tech stocks. The stock presents a value opportunity with a P/E of 16.06, below industry averages.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EW

No sentiment data available yet.

NTES
54% Buy46% Sell
Avg holding period · 74 Days

About Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.

Read more on EW →

About NetEase Inc

NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).

Read more on NTES →